Newron Pharmaceuticals SpA

FSX:NP5.DE

8.87 (EUR) • At close November 1, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

2023202220212020201920182017201620152014201320122011201020092008200720062005
Assets:
Current Assets:
Cash & Cash Equivalents 6.34113.42425.01913.21322.05227.62356.28642.94836.01118.75618.42629.2435.3678.08722.68941.26763.15774.76517.446
Short Term Investments 6.2649.359.57518.03717.11116.233.7953.524.926.9465.4573.641001.6050000
Cash and Short Term Investments 12.60522.77434.59431.2539.16343.85360.08146.46840.93125.70218.42629.2435.3678.08724.29441.26763.15774.76517.446
Net Receivables 5.1854.9584.0475.75619.46115.43511.2388.6541.9292.715.4573.6410000000
Inventory 00.7620.0040.846-0-15.4350.0050.0050.0380.1020.3010.2330.2460.3960.380.6570.5231.3450.739
Other Current Assets 1.872-0.0010.7820.0221.32215.65912.7149.6673.0053.584-2.387-0.372.0164.6237.0645.3135.8369.0223.095
Total Current Assets 19.66228.49339.42737.87459.94659.51272.856.1443.97429.38821.79732.7477.62913.10631.73847.23769.51685.13221.28
Non-Current Assets:
Property, Plant & Equipment, Net 0.4050.5270.5770.7340.2520.1060.1070.1210.080.0670.0790.0720.0560.1280.2410.480.4330.2910.441
Goodwill 000-0-000000000000000
Intangible Assets 000.0020.0110.020.030.0350.2610.2656.9939.12511.1995.1715.1888.97911.9890.0320.0460.085
Goodwill and Intangible Assets 000.0020.0110.020.030.0350.2610.2656.9939.12511.1995.1715.1888.97911.9890.0320.0460.085
Long Term Investments 0.0650.0740.0720.0640.070.0830.0820.070.062-6.362-4.873-3.05700-1.0210000
Tax Assets 00-0.072-0.064-0.07-0.083-0.082-0.07-0.0620000000000
Other Non-Current Assets 5.7478.10110.4812.5790.070.0830.0820.0690.0616.9885.493.6860.710.711.7410.8340.3870.6881.691
Total Non-Current Assets 6.2178.70211.05913.3240.3420.2190.2240.4510.4067.6869.82111.95.9376.0269.9413.3030.8521.0252.217
Total Assets 25.87937.19550.48651.19860.28859.73173.02456.59144.3837.07431.61844.64713.56619.13241.67860.5470.36886.15723.497
Liabilities & Equity:
Current Liabilities:
Account Payables 2.021.9091.5031.2732.4061.1492.2231.9831.6361.0461.3161.8810000000
Short Term Debt 22.4630.1720.150.1510.060.15100.3640.3620.3580.3580.3550.35500.2810.6260.2720.2720
Tax Payables 0000000000000000000
Deferred Revenue 00000-0.1510000000000000
Other Current Liabilities 4.4572.962.0015.4683.1293.1322.5044.2984.5153.0854.3969.3492.4724.6358.3749.3819.50112.5175.118
Total Current Liabilities 28.945.0413.6546.8925.5954.2814.7276.6456.5134.4896.0711.5852.8274.6358.65510.0079.77312.7895.118
Non-Current Liabilities:
Long Term Debt 25.76645.4942.93126.19416.8270.125000.3640.7291.0871.4471.8020-2.6580.2830.5610.8331.037
Deferred Revenue Non-Current 000000000000-3.16500.081-3.4121.9734.3270
Deferred Tax Liabilities Non-Current 00000000.0750.0752.2682.9053.5311.7181.7182.8583.755-2.262-4.8880
Other Non-Current Liabilities 1.0960.6940.7940.8661.0680.4810.5760.1240.3160.3270.4660.4763.7990.5883.4594.0962.9235.2380.322
Total Non-Current Liabilities 26.86146.18443.72527.0617.8950.6060.5760.1990.7553.3244.4585.4544.1542.3063.744.7223.1955.511.359
Total Liabilities 55.80151.22547.37933.95223.494.8875.3036.8447.2687.81310.52817.0396.9816.94112.39514.72912.96818.2996.477
Equity:
Preferred Stock 0000000000000000000
Common Stock 3.5713.5693.5693.5693.5693.5693.5673.1552.8442.6092.3252.2771.4531.4531.3121.2041.1671.1640.735
Retained Earnings -21.406-22.805-20.116-26.157-25.341-20.195-10.464-19.782-31.914-16.98-12.313-7.549-11.795-29.074-27.422-18.731-12.836-17.257-15.476
Accumulated Other Comprehensive Income/Loss 15.21914.97214.54113.73512.264-1.972-1.937-1.903-1.875-2.471-2.5-3.04-1.9030-1.7130000
Other Total Stockholders Equity -27.306-9.7665.11326.09946.30673.44276.55568.27768.05746.10333.57835.9218.8339.81257.10663.33869.06983.95131.761
Total Shareholders Equity -29.923-14.033.10717.24636.79854.84467.72149.74737.11229.26121.0927.6086.58512.19129.28345.81157.467.85817.02
Total Equity -29.923-14.033.10717.24636.79854.84467.72149.74737.11229.26121.0927.6086.58512.19129.28345.81157.467.85817.02
Total Liabilities & Shareholders Equity 25.87937.19550.48651.19860.28859.73173.02456.59144.3837.07431.61844.64713.56619.13241.67860.5470.36886.15723.497